PL452111A1 - Kompozycja hydrożelu regeneracyjnego do leczeniu ran - Google Patents
Kompozycja hydrożelu regeneracyjnego do leczeniu ranInfo
- Publication number
- PL452111A1 PL452111A1 PL452111A PL45211125A PL452111A1 PL 452111 A1 PL452111 A1 PL 452111A1 PL 452111 A PL452111 A PL 452111A PL 45211125 A PL45211125 A PL 45211125A PL 452111 A1 PL452111 A1 PL 452111A1
- Authority
- PL
- Poland
- Prior art keywords
- regenerative
- wound healing
- hydrogel composition
- wounds
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1858—Platelet-derived growth factor [PDGF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
- A61L15/32—Proteins, polypeptides; Degradation products or derivatives thereof, e.g. albumin, collagen, fibrin, gelatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2121/00—Preparations for use in therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Hematology (AREA)
- Materials Engineering (AREA)
- Dispersion Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Zoology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Dermatology (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Przedmiotem zgłoszenia jest kompozycja żelu regeneracyjnego dla komórek skóry charakteryzująca się tym, że zawiera kopolimer blokowy tlenku etylenu i tlenku propylenu i peptyd o sekwencji R1L2I3D4R5T6N7A8N9F10L11-NH2 (PDGF2). Kompozycja do stosowania jako lek, zwłaszcza do leczenia ran, zwłaszcza proregeneracyjnego leczenia ran lub ran będących skutkiem radioterapii.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP24177184 | 2024-05-21 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL452111A1 true PL452111A1 (pl) | 2025-11-24 |
Family
ID=97752663
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL452111A PL452111A1 (pl) | 2024-05-21 | 2025-05-21 | Kompozycja hydrożelu regeneracyjnego do leczeniu ran |
Country Status (1)
| Country | Link |
|---|---|
| PL (1) | PL452111A1 (pl) |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL237001B1 (pl) * | 2018-05-16 | 2021-03-08 | Gdanski Univ Medyczny | Nowy związek peptydowy jako czynnik stymulujący gojenie ran i rekonstrukcję skóry |
| CN118852487A (zh) * | 2024-07-02 | 2024-10-29 | 宁波市第二医院 | 一种抗菌肽聚合物及其制备方法与应用 |
| WO2024254694A1 (en) * | 2023-06-13 | 2024-12-19 | May Griffith | Mpc-based copolymers and hydrogels, and uses thereof in regenerative medicine |
-
2025
- 2025-05-21 PL PL452111A patent/PL452111A1/pl unknown
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL237001B1 (pl) * | 2018-05-16 | 2021-03-08 | Gdanski Univ Medyczny | Nowy związek peptydowy jako czynnik stymulujący gojenie ran i rekonstrukcję skóry |
| WO2024254694A1 (en) * | 2023-06-13 | 2024-12-19 | May Griffith | Mpc-based copolymers and hydrogels, and uses thereof in regenerative medicine |
| CN118852487A (zh) * | 2024-07-02 | 2024-10-29 | 宁波市第二医院 | 一种抗菌肽聚合物及其制备方法与应用 |
Non-Patent Citations (2)
| Title |
|---|
| M. DEPTUŁA I INN.:: "Original Research article, Front. Pharmacol., 28.11.2023, Sec. Experimental Pharmacology and Drug Discovery, Vol. 14 - 2023", DEVELOPMENT AND EVALUATION OF RADA-PDGF2 SELF-ASSEMBLING PEPTIDE HYDROGEL FOR ENHANCED SKIN WOUND HEALING, * |
| TONG GUAN I INN.:: "Adv. Sci. 2022, 9, 2104165", SELF-ASSEMBLING PEPTIDE-BASED HYDROGELS FOR WOUND TISSUE REPAIR, * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Weller et al. | Interactive dressings and their role in moist wound management | |
| Holmes IV et al. | Demonstration of the safety and effectiveness of the RECELL® System combined with split-thickness meshed autografts for the reduction of donor skin to treat mixed-depth burn injuries | |
| Pettigrew | Delayed primary wound closure in gangrenous and perforated appendicitis | |
| Khavanin et al. | Synergistic interactions with a high intraoperative expander fill volume increase the risk for mastectomy flap necrosis | |
| Al-Houraibi et al. | General assembly, prevention, wound management: proceedings of international consensus on orthopedic infections | |
| Devrukhkar et al. | Evaluation of isoamyl 2-cyanoacrylate tissue adhesive in management of pediatric lacerations: an alternative to suturing | |
| Stavrou et al. | Silicone-based scar therapy: a review of the literature | |
| Apelqvist et al. | Cold plasma: an emerging technology for clinical use in wound healing | |
| PL452111A1 (pl) | Kompozycja hydrożelu regeneracyjnego do leczeniu ran | |
| de Godoy et al. | Prevalence of cellulitis and erysipelas in post-mastectomy patients after breast cancer | |
| Khamise et al. | Acute healing outcomes in paediatric partial thickness burns using Epiprotect® and Biobrane®: a retrospective comparative study | |
| RU2284765C1 (ru) | Способ лечения флегмоны дна полости рта | |
| Kleintjes et al. | A prospective descriptive study of Cutimed Sorbact® used as a skin substitute for the treatment of partial thickness burn wounds | |
| Graham | Rabbit wound management | |
| WO2022019839A8 (en) | Crystalline zirconium phosphate for use in therapy, pharmaceutical composition, and use of the same | |
| Morioka et al. | Surgical site infection following dermatologic and plastic surgery in an office setting | |
| Thomas et al. | Management of scars | |
| Greco et al. | Carpal tunnel release complicated by necrotizing fasciitis | |
| Ellis et al. | Negative-pressure dressings in lower limb skin grafts: a randomised control trial of PICO versus standard dressings | |
| Selim et al. | Histological and Immunohistochemical Study on the Effect of Cyanoacrylate Topical Adhesive on Healing of Skin Wounds Versus Vicryl Suture Among Rabbits | |
| Farhangi et al. | Novel approach to skin closure following upper eyelid blepharoplasty | |
| CV et al. | A comparative study of the efficacy of human placental extract with collagen sheets in 20–40% partial thickness burns | |
| Alam et al. | Comparison of heparin dressing and conventional dressing in second degree burn patients in term of pain relief and wound healing. | |
| Watts et al. | Evidence Summary: Wound management-low resource communities: citric acid as a topical antiseptic | |
| PL425351A1 (pl) | Kompozycja zawierająca peptyd IM, zestaw oraz zastosowanie do pobudzania regeneracji tkanki złożonej lub leczenia ran |